Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 2/2023

25.11.2022 | Correction

Correction to: Preclinical development of ZED8, an 89Zr immuno‑PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy

verfasst von: Annie Ogasawara, James R. Kiefer, Herman Gill, Eugene Chiang, Shravan Sriraman, Gregory Z. Ferl, James Ziai, Sandra Sanabria Bohorquez, Sebastian Guelman, Xiangdan Wang, Jihong Yang, Minh Michael Phan, Van Nguyen, Shan Chung, Christine Yu, Jeff Tinianow, Stijn Jan Hein Waaijer, Alex De Crespigny, Jan Marik, C. Andrew Boswell, Tanja Zabka, Karin Staflin, Simon‑Peter Williams

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Excerpt

Correction to: European Journal of Nuclear Medicine and Molecular Imaging
Metadaten
Titel
Correction to: Preclinical development of ZED8, an 89Zr immuno‑PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy
verfasst von
Annie Ogasawara
James R. Kiefer
Herman Gill
Eugene Chiang
Shravan Sriraman
Gregory Z. Ferl
James Ziai
Sandra Sanabria Bohorquez
Sebastian Guelman
Xiangdan Wang
Jihong Yang
Minh Michael Phan
Van Nguyen
Shan Chung
Christine Yu
Jeff Tinianow
Stijn Jan Hein Waaijer
Alex De Crespigny
Jan Marik
C. Andrew Boswell
Tanja Zabka
Karin Staflin
Simon‑Peter Williams
Publikationsdatum
25.11.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 2/2023
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-022-06050-x

Weitere Artikel der Ausgabe 2/2023

European Journal of Nuclear Medicine and Molecular Imaging 2/2023 Zur Ausgabe